Passage Bio, Inc. (PASG)

4.65 -0.10 (-2.11%) USD  |  NASDAQ  |  Sep 04, 16:00
4.68 +0.03 (+0.65%) After-Hours: 20:00
More

Passage Bio EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --
Anika Therapeutics, Inc. Upgrade
Savara, Inc. --